Oral Biologics & Biosimilars Market Report 2026
Download Free Sample Buy Now
Oral Biologics & Biosimilars Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Oral Biologics & Biosimilars Market Report 2026

Global Outlook – By Therapy (Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases), By Molecule Type (Vaccines, Proteins and Peptides, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oral Biologics & Biosimilars Market Overview

• Oral Biologics & Biosimilars market size has reached to $9.37 billion in 2025

• Expected to grow to $24.69 billion in 2030 at a compound annual growth rate (CAGR) of 21.6%

• Growth Driver: Surging Prevalence Of Chronic Diseases Fuels Growth In Oral Biologics And Biosimilar Market

• Market Trend: Advancements In Smart Capsule Technologies For Oral Biologics And Biosimilars

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Oral Biologics & Biosimilars Market?

Biologics are drugs made from living cells using highly complex technology, while biosimilars are created to function similarly to biologics but are not identical to biologics. The oral biologics and biosimilars comprise biologics and biosimilar drugs taken orally for the targeted treatment of Alzheimer's, multiple sclerosis, HIV or AIDS, and other serious conditions and are used to treat chronic diseases such as diabetes, arthritis, and cancer.

The main therapy types of oral biologics and biosimilar lymphocytes are modulators, interleukin inhibitors, tumor necrosis factor-alpha inhibitors, immunostimulants, GPCR modulators, and others. Interleukin inhibitors are immunosuppressive drugs that stop interleukins from working. The various diseases include asthma, Crohn's disease, cancer, infectious disease, other autoimmune disease, and others that are treated by molecular types such as vaccines, proteins and peptides, monoclonal antibodies, and other therapies. These are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Oral Biologics & Biosimilars Market Global Report 2026 Market Report bar graph

What Is The Oral Biologics & Biosimilars Market Size and Share 2026?

The oral biologics & biosimilars market size has grown exponentially in recent years. It will grow from $9.37 billion in 2025 to $11.28 billion in 2026 at a compound annual growth rate (CAGR) of 20.3%. The growth in the historic period can be attributed to limited availability of oral biologics, high cost of biologic therapies, reliance on injectable formulations, increasing prevalence of chronic diseases, growing hospital and retail pharmacy networks.

What Is The Oral Biologics & Biosimilars Market Growth Forecast?

The oral biologics & biosimilars market size is expected to see exponential growth in the next few years. It will grow to $24.69 billion in 2030 at a compound annual growth rate (CAGR) of 21.6%. The growth in the forecast period can be attributed to development of biosimilars and combination therapies, expansion of oral biologics pipelines, increasing patient preference for oral medications, rising adoption of digital adherence tools, growing government support and reimbursement policies. Major trends in the forecast period include rising adoption of oral biologics and biosimilars for chronic diseases, growth in targeted therapies for diabetes, arthritis, and cancer, increasing development of monoclonal antibody-based oral treatments, expansion of hospital, retail, and online pharmacy distribution channels, focus on patient adherence and personalized treatment plans.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Oral Biologics & Biosimilars Market Segmentation

1) By Therapy: Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies

2) By Disease: Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases

3) By Molecule Type: Vaccines, Proteins and Peptides, Other Molecule Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Lymphocyte Modulators: T-Cell Modulators, B-Cell Modulators, Sphingosine-1-Phosphate Receptor Modulators

2) By Immunostimulants: Cytokines, Immune Checkpoint Inhibitors, Adjuvants

3) By GPCR Modulators: Agonists, Antagonists, Biased Ligands

4) By Other Therapies: Cell-Based Therapies, Gene Therapies, Combination Therapies

What Is The Driver Of The Oral Biologics & Biosimilars Market?

The rising prevalence of chronic diseases is expected to propel the growth of the oral biologics and biosimilar market going forward. Chronic diseases refer to long-lasting medical conditions that typically progress slowly, such as diabetes, cardiovascular diseases, and respiratory disorders. The rise in chronic diseases is largely driven by sedentary lifestyles, as prolonged physical inactivity increases the risk of obesity, heart disease, type 2 diabetes, and certain cancers. Oral biologics and biosimilars support this shift by providing more accessible, cost-effective, and convenient treatment options for patients managing chronic conditions. For instance, in January 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, 76.4% of U.S. adults (approximately 194 million people) reported having at least one chronic condition, with prevalence rates of 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the rising prevalence of chronic diseases is driving the growth of the oral biologics and biosimilar market.

Key Players In The Global Oral Biologics & Biosimilars Market

Major companies operating in the oral biologics & biosimilars market are Merck & Co. Inc., GlaxoSmithKline, Novo Nordisk, BiosanaPharma, AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi, Microgen, Geropharm, Valenta, NovaMedica, SynBio, Roche, Rani Therapeutics, Eli Lilly and Company, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Abbvie, Johnson & Johnson, Pfizer Inc., Biogen Inc., Aché, Eurofarma, Teva Pharmaceuticals, Oramed Pharmaceuticals, Entera Bio, Julphar, Hikma Pharmaceuticals, Altis Biologics, Cipla Medpro South Africa, Genzyme

Global Oral Biologics & Biosimilars Market Trends and Insights

Major companies operating in the oral biologics & biosimilars market are focusing on developing innovative solutions, such as tailored smart capsule development services, to improve oral delivery of biologics, enhance bioavailability, and enable patient-friendly administration compared with traditional injectable formulations. Smart capsules are designed with advanced coatings, controlled-release matrices, or protective excipients that safeguard biologics from degradation in the gastrointestinal tract and optimize absorption in targeted regions of the intestine, offering a non-invasive alternative to injections and improving patient adherence. For instance, in December 2024, Lonza Group AG, a Switzerland-based contract development and manufacturing organization (CDMO), launched a tailored service for smart capsule development, specifically supporting oral biologics development. The service encompasses customized formulation design, protective excipient selection, and capsule engineering to ensure stability and targeted release of biologics; it functions by enhancing the oral bioavailability of sensitive biomolecules while maintaining therapeutic efficacy; unique features include end-to-end support from concept to preclinical testing, compatibility with multiple biologic modalities (proteins, peptides, nucleic acids), and scalable manufacturing solutions; applications span oral delivery of monoclonal antibodies, therapeutic peptides, and vaccines; benefits include improved patient convenience, reduced reliance on injections, enhanced compliance, and accelerated development timelines for oral biologic therapies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Oral Biologics & Biosimilars Market?

In September 2023, Biocon Limited., an India-based pharmaceutical company, acquired Eywa Pharma Inc. for an amount of $7.7 million. The acquisition additionally enables businesses to diversify their manufacturing infrastructure, ensuring supply continuity and providing oral solid dosage capacities for new products ahead of schedule. Eywa Pharma Inc. is a US-based pharmaceutical company that specializes in oral biologics and biosimilars.

Regional Insights

North America was the largest region in the oral biologics and biosimilar drugs market in 2025. The Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Biologics & Biosimilars Market?

The oral biologics and biosimilar market consists of sales of receptor modulators, biological agents, and biosimilar lymphocytes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Biologics & Biosimilars Market Report 2026?

The oral biologics & biosimilars market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oral biologics & biosimilars industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Oral Biologics & Biosimilars Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $11.28 billion
Revenue Forecast In 2035 $24.69 billion
Growth Rate CAGR of 20.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy, Disease, Molecule Type, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., GlaxoSmithKline, Novo Nordisk, BiosanaPharma, AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi, Microgen, Geropharm, Valenta, NovaMedica, SynBio, Roche, Rani Therapeutics, Eli Lilly and Company, Emisphere Technologies Inc., Enteris BioP
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oral Biologics & Biosimilars Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oral Biologics & Biosimilars Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oral Biologics & Biosimilars Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oral Biologics & Biosimilars Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Oral Biologics And Biosimilars For Chronic Diseases

4.2.2 Growth In Targeted Therapies For Diabetes, Arthritis, And Cancer

4.2.3 Increasing Development Of Monoclonal Antibody-Based Oral Treatments

4.2.4 Expansion Of Hospital, Retail, And Online Pharmacy Distribution Channels

4.2.5 Focus On Patient Adherence And Personalized Treatment Plans

5. Oral Biologics & Biosimilars Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Online Pharmacies

5.4 Specialty Clinics

5.5 Biotechnology And Pharmaceutical Companies

6. Oral Biologics & Biosimilars Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oral Biologics & Biosimilars Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oral Biologics & Biosimilars PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oral Biologics & Biosimilars Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oral Biologics & Biosimilars Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oral Biologics & Biosimilars Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oral Biologics & Biosimilars Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oral Biologics & Biosimilars Market Segmentation

9.1. Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies

9.2. Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases

9.3. Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccines, Proteins and Peptides, Other Molecule Types

9.4. Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

T-Cell Modulators, B-Cell Modulators, Sphingosine-1-Phosphate Receptor Modulators

9.6. Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Immunostimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytokines, Immune Checkpoint Inhibitors, Adjuvants

9.7. Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of GPCR Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Agonists, Antagonists, Biased Ligands

9.8. Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell-Based Therapies, Gene Therapies, Combination Therapies

10. Oral Biologics & Biosimilars Market Regional And Country Analysis

10.1. Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oral Biologics & Biosimilars Market

11.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oral Biologics & Biosimilars Market

12.1. China Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oral Biologics & Biosimilars Market

13.1. India Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oral Biologics & Biosimilars Market

14.1. Japan Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oral Biologics & Biosimilars Market

15.1. Australia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oral Biologics & Biosimilars Market

16.1. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oral Biologics & Biosimilars Market

17.1. South Korea Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oral Biologics & Biosimilars Market

18.1. Taiwan Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oral Biologics & Biosimilars Market

19.1. South East Asia Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oral Biologics & Biosimilars Market

20.1. Western Europe Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oral Biologics & Biosimilars Market

21.1. UK Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oral Biologics & Biosimilars Market

22.1. Germany Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oral Biologics & Biosimilars Market

23.1. France Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oral Biologics & Biosimilars Market

24.1. Italy Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oral Biologics & Biosimilars Market

25.1. Spain Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oral Biologics & Biosimilars Market

26.1. Eastern Europe Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oral Biologics & Biosimilars Market

27.1. Russia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oral Biologics & Biosimilars Market

28.1. North America Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oral Biologics & Biosimilars Market

29.1. USA Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oral Biologics & Biosimilars Market

30.1. Canada Oral Biologics & Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oral Biologics & Biosimilars Market

31.1. South America Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oral Biologics & Biosimilars Market

32.1. Brazil Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oral Biologics & Biosimilars Market

33.1. Middle East Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oral Biologics & Biosimilars Market

34.1. Africa Oral Biologics & Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Oral Biologics & Biosimilars Market, Segmentation By Therapy, Segmentation By Disease, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oral Biologics & Biosimilars Market Regulatory and Investment Landscape

36. Oral Biologics & Biosimilars Market Competitive Landscape And Company Profiles

36.1. Oral Biologics & Biosimilars Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oral Biologics & Biosimilars Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oral Biologics & Biosimilars Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novo Nordisk Overview, Products and Services, Strategy and Financial Analysis

36.3.4. BiosanaPharma Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis

37. Oral Biologics & Biosimilars Market Other Major And Innovative Companies

Bayer, Boehringer Ingelheim, Sanofi, Microgen, Geropharm, Valenta, NovaMedica, SynBio, Roche, Rani Therapeutics, Eli Lilly and Company, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, AbbVie

38. Global Oral Biologics & Biosimilars Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market

40. Oral Biologics & Biosimilars Market High Potential Countries, Segments and Strategies

40.1 Oral Biologics & Biosimilars Market In 2030 - Countries Offering Most New Opportunities

40.2 Oral Biologics & Biosimilars Market In 2030 - Segments Offering Most New Opportunities

40.3 Oral Biologics & Biosimilars Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Oral Biologics & Biosimilars Market, Overview Of Key Products - Product Examples
  • Table 2: Global Oral Biologics & Biosimilars Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Oral Biologics & Biosimilars Market, Supply Chain Analysis
  • Table 4: Global Oral Biologics & Biosimilars Market, Major Raw Material Providers
  • Table 5: Global Oral Biologics & Biosimilars Market, Major Resource Providers
  • Table 6: Global Oral Biologics & Biosimilars Market, Major Manufacturers (Suppliers)
  • Table 7: Global Oral Biologics & Biosimilars Market, Major Distributors And Channel Partners
  • Table 8: Global Oral Biologics & Biosimilars Market, Key Technologies & Future Trends
  • Table 9: Global Oral Biologics & Biosimilars Market, Major Trends
  • Table 10: Global Oral Biologics & Biosimilars Market, Major End Users
  • Table 11: Global Oral Biologics & Biosimilars Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Oral Biologics & Biosimilars Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Oral Biologics & Biosimilars Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Oral Biologics & Biosimilars Market - TAM, US$ Billion, 2025
  • Table 15: Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Immunostimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of GPCR Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Oral Biologics & Biosimilars Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Oral Biologics & Biosimilars Market - Company Scoring Matrix
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: GlaxoSmithKline Financial Performance
  • Table 101: Novo Nordisk Financial Performance
  • Table 102: BiosanaPharma Financial Performance
  • Table 103: AstraZeneca Financial Performance
  • Table 104: Global Oral Biologics & Biosimilars Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Oral Biologics & Biosimilars Market, Competitive Dashboard
  • Table 106: Global Oral Biologics & Biosimilars Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Table 108: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Table 109: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

List Of Figures

    Figure 1: Global Oral Biologics & Biosimilars Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Oral Biologics & Biosimilars Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Oral Biologics & Biosimilars Market, Supply Chain Analysis
  • Figure 4: Global Oral Biologics & Biosimilars Market, Major Raw Material Providers
  • Figure 5: Global Oral Biologics & Biosimilars Market, Major Resource Providers
  • Figure 6: Global Oral Biologics & Biosimilars Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Oral Biologics & Biosimilars Market, Major Distributors And Channel Partners
  • Figure 8: Global Oral Biologics & Biosimilars Market, Key Technologies & Future Trends
  • Figure 9: Global Oral Biologics & Biosimilars Market, Major Trends
  • Figure 10: Global Oral Biologics & Biosimilars Market, Major End Users
  • Figure 11: Global Oral Biologics & Biosimilars Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Oral Biologics & Biosimilars Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Oral Biologics & Biosimilars Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Oral Biologics & Biosimilars Market - TAM, US$ Billion, 2025
  • Figure 15: Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Lymphocyte Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Immunostimulants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of GPCR Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Oral Biologics & Biosimilars Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Oral Biologics & Biosimilars Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Oral Biologics & Biosimilars Market - Company Scoring Matrix
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: GlaxoSmithKline Financial Performance
  • Figure 101: Novo Nordisk Financial Performance
  • Figure 102: BiosanaPharma Financial Performance
  • Figure 103: AstraZeneca Financial Performance
  • Figure 104: Global Oral Biologics & Biosimilars Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Oral Biologics & Biosimilars Market, Competitive Dashboard
  • Figure 106: Global Oral Biologics & Biosimilars Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Figure 108: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Figure 109: Global, Oral Biologics & Biosimilars Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Read More About Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Read More About Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route O...

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Analgesics Market Report 2026 - Global Outlook – By Type (Non-opioids, Opioids ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores ), By Application (Internal Analgesics, External Analgesics )...

Diuretics Market Report 2026 - Global Outlook – By Type (Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides And Thiazide-Like Diuretics, Aldosterone Antagonists ), By Distribution (Hospital Pharm...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia ), By Route of Administration (Oral, Injecta...

Generic Pharmaceuticals Market Report 2026 - Global Outlook – By Type (Biosimilars, Generics), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaled), By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Ha...

Frequently Asked Questions

The Oral Biologics & Biosimilars Market Report 2026 market was valued at $9.37 billion in 2025, increased to $11.28 billion in 2026, and is projected to reach $24.69 billion by 2030. request a sample here

The expected CAGR for the Oral Biologics & Biosimilars Market Report 2026 market during the forecast period 2025–2030 is 21.6%. request a sample here

Major growth driver of the market includes: Surging Prevalence Of Chronic Diseases Fuels Growth In Oral Biologics And Biosimilar Market in the Oral Biologics & Biosimilars Market Report 2026 market. For further insights on this market, request a sample here

The oral biologics & biosimilars market covered in this report is segmented –
1) By Therapy: Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies
2) By Disease: Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases
3) By Molecule Type: Vaccines, Proteins and Peptides, Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Lymphocyte Modulators: T-Cell Modulators, B-Cell Modulators, Sphingosine-1-Phosphate Receptor Modulators
2) By Immunostimulants: Cytokines, Immune Checkpoint Inhibitors, Adjuvants
3) By GPCR Modulators: Agonists, Antagonists, Biased Ligands
4) By Other Therapies: Cell-Based Therapies, Gene Therapies, Combination Therapies request a sample here

Major trend in this market includes: Advancements In Smart Capsule Technologies For Oral Biologics And Biosimilars For further insights on this market, request a sample here.

Major companies operating in the Oral Biologics & Biosimilars Market Report 2026 market are Major companies operating in the oral biologics & biosimilars market are Merck & Co. Inc., GlaxoSmithKline, Novo Nordisk, BiosanaPharma, AstraZeneca, Bayer, Boe request a sample here.

North America was the largest region in the oral biologics and biosimilar drugs market in 2025. The Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in the oral biologics & biosimilars market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us